Makers of just 10 drugs may have shortchanged the nation's Medicaid system by at least $1.3 billion from 2012 through 2016 by misclassifying their products in a rebate program, a government analysis found.
Trending:
Drug companies may have shorted government more than $1 billion in Medicaid rebates